Literature DB >> 15976010

Large-scale modelling as a route to multiple surface comparisons of the CCP module family.

Dinesh C Soares1, Dietlind L Gerloff, Neil R Syme, Andrew F W Coulson, John Parkinson, Paul N Barlow.   

Abstract

Numerous mammalian proteins are constructed from a limited repertoire of module-types. Proteins belonging to the regulators of complement activation family--crucial for ensuring a complement-mediated immune response is targeted against infectious agents--are composed solely of complement control protein (CCP) modules. In the current study, CCP module sequences were grouped to allow selection of the most appropriate experimentally determined structures to serve as templates in an automated large-scale structure modelling procedure. The resulting 135 individual CCP module models, valuable in their own right, are available at the online database http://www.bru.ed.ac.uk/~dinesh/ccp-db.html. Comparisons of surface properties within a particular family of modules should be more informative than sequence alignments alone. A comparison of surface electrostatic features was undertaken for the first 28 CCP modules of complement receptor type 1 (CR1). Assignments to clusters based on surface properties differ from assignments to clusters based on sequences. This observation might reflect adaptive evolution of surface-exposed residues involved in protein-protein interactions. This illustrative example of a multiple surface-comparison was indeed able to pinpoint functional sites in CR1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976010     DOI: 10.1093/protein/gzi039

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  23 in total

1.  The origins of apicomplexan sequence innovation.

Authors:  James Wasmuth; Jennifer Daub; José Manuel Peregrín-Alvarez; Constance A M Finney; John Parkinson
Journal:  Genome Res       Date:  2009-04-10       Impact factor: 9.043

2.  Estimation of interdomain flexibility of N-terminus of factor H using residual dipolar couplings.

Authors:  Mateusz Maciejewski; Nico Tjandra; Paul N Barlow
Journal:  Biochemistry       Date:  2011-08-31       Impact factor: 3.162

Review 3.  Protection of host cells by complement regulators.

Authors:  Christoph Q Schmidt; John D Lambris; Daniel Ricklin
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

4.  With phases: how two wrongs can sometimes make a right.

Authors:  Pietro Roversi; Steven Johnson; Susan M Lea
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

5.  SRPX2 Enhances the Epithelial-Mesenchymal Transition and Temozolomide Resistance in Glioblastoma Cells.

Authors:  Haitao Tang; Jiaxin Zhao; Liangyu Zhang; Jiang Zhao; Yongzhi Zhuang; Peng Liang
Journal:  Cell Mol Neurobiol       Date:  2015-12-07       Impact factor: 5.046

6.  A secreted complement-control-related protein ensures acetylcholine receptor clustering.

Authors:  Marie Gendrel; Georgia Rapti; Janet E Richmond; Jean-Louis Bessereau
Journal:  Nature       Date:  2009-09-30       Impact factor: 49.962

Review 7.  BRCT domains: A little more than kin, and less than kind.

Authors:  Dietlind L Gerloff; Nicholas T Woods; April A Farago; Alvaro N A Monteiro
Journal:  FEBS Lett       Date:  2012-05-11       Impact factor: 4.124

Review 8.  Complement factor H: using atomic resolution structure to illuminate disease mechanisms.

Authors:  Paul N Barlow; Gregory S Hageman; Susan M Lea
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 9.  Translational mini-review series on complement factor H: structural and functional correlations for factor H.

Authors:  C Q Schmidt; A P Herbert; H G Hocking; D Uhrín; P N Barlow
Journal:  Clin Exp Immunol       Date:  2008-01       Impact factor: 4.330

10.  The central portion of factor H (modules 10-15) is compact and contains a structurally deviant CCP module.

Authors:  Christoph Q Schmidt; Andrew P Herbert; Haydyn D T Mertens; Mara Guariento; Dinesh C Soares; Dusan Uhrin; Arthur J Rowe; Dmitri I Svergun; Paul N Barlow
Journal:  J Mol Biol       Date:  2009-10-14       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.